Company Info

Lyophilization Technology, Inc.

CDMO

Overview

Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products. LTI is focused on bringing new products to the clinic and implementing improvements for current products, with capabilities in product development, process engineering, clinical manufacturing, and technical support. LTI has provided Development and Clinical Trial Material Manufacturing services to more than 454 biotechnology and pharmaceutical organizations spanning virtual companies to large multi-national corporations for over 24 years, boasting a proven track record of performance comes from successfully developing formulations, manufacturing processes, and prepared material for clinical trials for over 868 diverse products.

Company Services

Services/CapabilitiesCDMO

+ Development Services

Analytical Development & Validation
Bioanalytical Services
Preformulation/Formulation
Process Development & Validation
Scale Up/Tech Transfer

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)
Lyophilized Products Manufacturing
Sterile Bags Manufacturing

+ Drug Substance Manufacturing

Controlled Substances
Cytotoxic / High Potency Compounds (OEL < 1µg/m3)

+ Packaging

Prefilled Syringes/Cartridges/Pen Devices